White-label equity research, fundraising and investor readiness support, commercial due diligence, investment-linked market intelligence, and capital allocation advisory - built on the same methodological foundation as the primary services, delivered under the client's name.
Research advisory work tends to fail in one of three ways. Fundraising materials are produced by designers rather than analysts, so the deck looks polished, but the valuation basis cannot survive the first serious investor question. Due diligence reports describe risks that are already visible in the public filings without surfacing the specific assumption underneath the revenue projection that changes the investment case. Market intelligence is pulled from published reports and presented as proprietary insight - the same secondary data the client already has access to, repackaged.
Fundraising materials are built from the financial architecture up: pre-money and post-money valuations, cap table mechanics, and IRR analysis established before the pitch deck is designed, not after. Commercial due diligence is structured to find the specific risk that changes the decision, not the risks that confirm the thesis is broadly sound. Market intelligence is produced from primary and secondary research combined, where secondary data establishes the empirical baseline and primary field intelligence tests whether that baseline reflects how the market is actually moving. Every output is produced to the standard the client's institutional audience will apply to it.
The supporting work is only worth commissioning if it changes something the primary analysis would have missed. If it only confirms what the deal team already believed, the brief was not asking the right questions.
Brokerage firms and sell-side research desks that need white-label equity research and sector coverage support produced to institutional standard, published under their brand.
Founders and CFOs preparing for a capital raise where the investor will open the financial model, run their own scenarios, and ask about the assumptions. A compelling deck opens the door. The model and the underlying valuation basis are what keep the conversation in the room.
PE and VC deal teams who need a commercial view that is independent of the management presentation, structured to surface the specific risk that changes the decision rather than the risks already visible in the information memorandum.
Investment committees and leadership teams where capital allocation itself is the structural question: how to sequence investments across a portfolio, how to evaluate competing growth paths, or how to build the research infrastructure that supports ongoing allocation decisions at an institutional standard.
Research advisory work is not produced in parallel with the core evaluation. They are produced as part of the same integrated engagement where the brief calls for it. A fundraising package and the financial model underpinning its valuation are one piece of work, not two deliverables aligned at the end. A commercial due diligence report and the deal model run simultaneously, with qualitative findings feeding directly into quantitative assumptions as both develop. Market intelligence is built to feed the model's revenue assumptions, not to sit in a separate report.
Primary source validation runs across all of them. Company filings, sector benchmarking, primary channel research, and expert interviews are used before the methodological framework is set, not as a check after the conclusion has been reached. Every engagement is senior-led throughout: the analyst who scopes the engagement is the one who delivers it.
A pitch deck agency produces a presentation. We build the financial architecture that the presentation has to be consistent with. The valuation basis, the scenario analysis, the IRR and exit multiple projections, and the cap table mechanics are established before the deck is designed: the deck is then built on top of that foundation rather than as a parallel document that broadly aligns with it. When the investor opens the model, asks about the assumptions, or runs their own scenario, the answer to every question is already in the analytical work. That is a different brief from deck design.
Secondary research establishes the analytical landscape: what published market reports, transaction databases, and sector benchmarks show about the size, structure, and competitive dynamics of the market. Primary research tests whether that landscape reflects how the market is actually moving: expert interviews, channel checks, and field research that surfaces the pricing dynamics, customer acquisition patterns, and competitive behaviour that do not appear in published data. The two work together because secondary data tells you what the market looks like on paper, and primary intelligence tells you which parts of that picture to trust and which to revise before the model's assumptions are set.
Yes, but the financial architecture at each stage is different and the valuation framework has to reflect that. A Seed round model is built around unit economics, burn rate, and the milestone the capital is being raised to reach. A Series C model is built around a three-statement integrated forecast, comparable transaction analysis, and IRR projections for institutional investors underwriting the specific return profile they need at that stage. A pre-IPO model is built to the standard an equity analyst will interrogate in the first week of coverage initiation. We build each model for the specific investor class and capital stage, not from a general template.
No. Every Research Advisory output goes out under the client's name. Equity research is published under the brokerage's brand. Fundraising materials carry the founder's or the company's name. Due diligence reports are produced for the deal team's internal use. We produce the analytical work. The client owns it, publishes it, and takes responsibility for it. Perusal does not appear in the output, the distribution, or the client relationship.
A focused red-flag due diligence engagement, structured to surface the specific risks affecting a transaction at the point of commitment, typically runs two to four weeks from briefing to report. A full commercial due diligence covering revenue assumption validation, competitive landscape assessment, and governance and regulatory risk, with primary research interviews, typically runs four to eight weeks depending on the complexity of the business and the number of markets covered. For transactions where the timeline is compressed, we scope to what the deal window requires and are direct about what can and cannot be validated within that constraint.
The first conversation is about the specific decision you are facing: the raise, the deal, the coverage mandate, or the capital allocation question. Research Advisory engagements are scoped to the decision, not to a service template.
